Expression of p53-protein, epidermal growth factor receptor (EGFR) and proliferating cell antigens in human gliomas.
Paraffin-embedded surgical specimens from 56 human astrocytomas (8 pilocytic [I degree] astrocytomas, 9 low grade [II degrees] fibrillary astrocytomas, 9 high grade [III degrees] astrocytomas and 30 glioblastomas) were immunostained with the anti-PCNA, anti-p53, anti-Ki-67 and anti EGFR antibodies. Approximately 41% of all cases were p53 protein-positive while 23% were EGFR positive. Five cases (8.9%) were positive for both p53 protein and EGFR. Low grade gliomas showed low PCNA LI while high PCNA LI was observed in high grade gliomas. The same trend was observed with anti-Ki-67 antibodies but the proportion of Ki-67 immunolabelled cells was always much lower. In conclusion, we found two populations of astrocytic tumors with EGFR and with p53 protein overexpression but no dependence between p53 immunoreactivity and PCNA or Ki-67 LI.
Kordek
R
R
Department of Cancer Pathology, Institute of Oncology, School of Medicine, Lódź.
Bratosiewicz
J
J
Biernat
W
W
Alwasiak
J
J
Liberski
P P
PP
D066246:ErbB Receptors; D015870:Gene Expression; D016158:Genes, p53; D005910:Glioma / Q000235:genetics* / Q000473:pathology; D006801:Humans; D009367:Neoplasm Staging; D018809:Proliferating Cell Nuclear Antigen / Q000276:immunology*
D018809:Proliferating Cell Nuclear Antigen; D066246:ErbB Receptors